AU2002303250B2 - Methods of treating acne - Google Patents

Methods of treating acne Download PDF

Info

Publication number
AU2002303250B2
AU2002303250B2 AU2002303250A AU2002303250A AU2002303250B2 AU 2002303250 B2 AU2002303250 B2 AU 2002303250B2 AU 2002303250 A AU2002303250 A AU 2002303250A AU 2002303250 A AU2002303250 A AU 2002303250A AU 2002303250 B2 AU2002303250 B2 AU 2002303250B2
Authority
AU
Australia
Prior art keywords
hydrogen
amino
acne
halogen
tetracycline compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU2002303250A
Other languages
English (en)
Other versions
AU2002303250A1 (en
Inventor
Robert A. Ashley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Collagenex Pharmaceuticals Inc
Original Assignee
Collagenex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23079310&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2002303250(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Collagenex Pharmaceuticals Inc filed Critical Collagenex Pharmaceuticals Inc
Publication of AU2002303250A1 publication Critical patent/AU2002303250A1/en
Application granted granted Critical
Publication of AU2002303250B2 publication Critical patent/AU2002303250B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2002303250A 2001-04-05 2002-04-05 Methods of treating acne Expired AU2002303250B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28191601P 2001-04-05 2001-04-05
US60/281,916 2001-04-05
PCT/US2002/010747 WO2002080932A1 (en) 2001-04-05 2002-04-05 Methods of treating acne

Publications (2)

Publication Number Publication Date
AU2002303250A1 AU2002303250A1 (en) 2003-04-10
AU2002303250B2 true AU2002303250B2 (en) 2006-05-25

Family

ID=23079310

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002303250A Expired AU2002303250B2 (en) 2001-04-05 2002-04-05 Methods of treating acne

Country Status (12)

Country Link
EP (4) EP1716856A3 (enExample)
JP (3) JP2004536046A (enExample)
KR (1) KR100926326B1 (enExample)
AT (1) ATE330615T1 (enExample)
AU (1) AU2002303250B2 (enExample)
CA (2) CA2719162C (enExample)
DE (1) DE60212613T2 (enExample)
DK (1) DK1383508T3 (enExample)
ES (1) ES2266499T3 (enExample)
NZ (1) NZ528197A (enExample)
PT (1) PT1383508E (enExample)
WO (1) WO2002080932A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2311797A1 (en) * 2002-01-08 2011-04-20 Paratek Pharmaceuticals, Inc. 4-dedimethylamino tetracycline compounds
US8192749B2 (en) 2003-04-16 2012-06-05 Galderma Laboratories Inc. Methods of simultaneously treating ocular rosacea and acne rosacea
WO2003088906A2 (en) * 2002-04-16 2003-10-30 Collagenex Pharmaceuticals, Inc. Methods of simultaneously treating ocular rosacea and acne rosacea
CA2521885C (en) 2003-04-07 2013-06-25 Shire Laboratories, Inc. Once daily formulations of tetracyclines
NZ544826A (en) 2003-07-25 2008-07-31 Warner Chilcott Co Inc A doxycycline metal complex in a solid dosage form
EP1684768A4 (en) * 2003-11-06 2007-06-06 Univ New York State Res Found METHOD FOR TREATING ECCEM
US9192615B2 (en) 2008-08-06 2015-11-24 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US7544373B2 (en) 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7541347B2 (en) 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
US7704959B2 (en) * 2006-10-03 2010-04-27 Dow Pharmaceutical Sciences Azithromycin for the treatment of nodular acne
JP5395052B2 (ja) * 2007-03-23 2014-01-22 モレキュラー リサーチ センター インコーポレイテッド 炎症を処置するための組成物および方法
WO2008121107A1 (en) * 2007-04-02 2008-10-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
MX2010012385A (es) * 2008-05-16 2010-12-02 Galderma Res & Dev Regimen de terapia para tratar enfermedades relacionadas al acne.
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
KR20140146095A (ko) * 2012-04-19 2014-12-24 갈데르마 소시에떼아노님 여드름의 치료 방법
RU2557991C1 (ru) * 2014-05-19 2015-07-27 Вячеслав Владимирович Чеботарёв Способ лечения больных вульгарными угрями (акне), страдающих дисплазией соединительной ткани
CO2017001953A1 (es) * 2017-02-27 2018-08-31 Corporacion Univ Lasallista Método de encapsulación de tetraciclinas
CA3070663A1 (en) * 2017-07-21 2019-01-24 Almirall, Llc Treatment of non-inflammatory lesions
MX2020007222A (es) * 2018-01-07 2020-12-10 Dr Reddys Laboratories Ltd Metodos para el tratamiento de afecciones inflamatorias de la piel.
CA3125456A1 (en) * 2019-01-04 2020-07-09 Dermata Therapeutics, Llc Compositions and methods for the treatment of skin conditions
WO2021215405A1 (ja) * 2020-04-20 2021-10-28 国立大学法人大阪大学 免疫賦活化剤、及び治療又は予防用組成物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5827840A (en) * 1996-08-01 1998-10-27 The Research Foundation Of State University Of New York Promotion of wound healing by chemically-modified tetracyclines

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983000628A1 (en) * 1981-08-27 1983-03-03 Bernstein, Joel, E. A method of treating acne vulgaris and composition containing carbamide peroxide
US5122519A (en) * 1989-06-27 1992-06-16 American Cyanamid Company Stable, cosmetically acceptable topical gel formulation and method of treatment for acne
JP3170277B2 (ja) * 1990-08-16 2001-05-28 マーチン，ネイル・エフ 眼瞼炎の局所治療
US5674539A (en) * 1994-12-09 1997-10-07 Tomas; Robert E. Method of treating skin and composition
FR2730930B1 (fr) * 1995-02-27 1997-04-04 Oreal Utilisation d'inhibiteurs de no-synthase pour diminuer l'effet irritant cutane de produits utilises dans le domaine cosmetique ou pharmaceutique
US5789395A (en) * 1996-08-30 1998-08-04 The Research Foundation Of State University Of New York Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
US5908838A (en) * 1998-02-19 1999-06-01 Medics Pharmaceutical Corporation Method for the treatment of acne
US6432934B1 (en) * 1998-08-06 2002-08-13 Advanced Vision Research Methods and compositions for topical treatment of eye surface inflammation and related dry eye disease
US6015804A (en) * 1998-09-11 2000-01-18 The Research Foundation Of State University Of New York Method of using tetracycline compounds to enhance interleukin-10 production
EP1124558A4 (en) * 1998-09-28 2004-10-27 Res Foundation Ofstate Univers NEW INHIBITANT AGAINST CATARACT EDUCATION
US5998390A (en) * 1998-09-28 1999-12-07 The Research Foundation Of State University Of New York Combination of bisphosphonate and tetracycline
ES2272097T3 (es) * 1998-11-18 2007-04-16 Collagenex Pharmaceuticals, Inc. Nuevos derivados de 4-desdimetilaminotetraciclina.
JP2001072660A (ja) * 1999-09-08 2001-03-21 Welfide Corp ＴＮＦ−α産生抑制剤および／またはＩＬ−１０産生促進剤

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5827840A (en) * 1996-08-01 1998-10-27 The Research Foundation Of State University Of New York Promotion of wound healing by chemically-modified tetracyclines

Also Published As

Publication number Publication date
EP2221056A1 (en) 2010-08-25
WO2002080932A1 (en) 2002-10-17
CA2440472A1 (en) 2002-10-17
JP2011168613A (ja) 2011-09-01
EP1716856A2 (en) 2006-11-02
JP2004536046A (ja) 2004-12-02
KR100926326B1 (ko) 2009-11-12
JP2010053155A (ja) 2010-03-11
EP1383508A1 (en) 2004-01-28
EP1383508B1 (en) 2006-06-21
DE60212613T2 (de) 2007-05-24
CA2440472C (en) 2011-01-18
KR20040007488A (ko) 2004-01-24
ES2266499T3 (es) 2007-03-01
ATE330615T1 (de) 2006-07-15
EP1716856A3 (en) 2009-02-18
DE60212613D1 (de) 2006-08-03
NZ528197A (en) 2007-04-27
DK1383508T3 (da) 2006-12-27
EP1383508A4 (en) 2005-07-06
CA2719162A1 (en) 2002-10-17
EP1712236A2 (en) 2006-10-18
CA2719162C (en) 2014-12-23
EP1712236A3 (en) 2008-05-28
PT1383508E (pt) 2006-11-30

Similar Documents

Publication Publication Date Title
US10058564B2 (en) Methods of treating acne
CA2440472C (en) Methods of treating acne
AU2002303250A1 (en) Methods of treating acne
AU2003230935B2 (en) Methods of simultaneously treating ocular rosacea and acne rosacea
US20120220555A1 (en) Methods of Simultaneously Treating Ocular Rosacea and Acne Rosacea
US20050153943A1 (en) Methods of simultaneously treating mucositis and fungal infection
EP1505961A1 (en) Methods of treating allergic reactions

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired